Cite

HARVARD Citation

    Spiegl-Kreinecker, S. et al. (2018). TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro-oncology. 20 (12), pp. 1584-1593. [Online]. 
  
Back to record